TaiGen Biotechnology Company Ltd, a biotechnology firm in Taiwan, has given Russia's R-Pharm the exclusive license to develop and commercialize the anti-infective compound nemonoxacin in the Russian Federation, Turkey and the Commonwealth of Independent States.
Breaking News
